Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study.

Leroux-Roels, Geert

Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study. [electronic resource] - Vaccine Nov 2014 - 6838-46 p. digital

Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1873-2518

10.1016/j.vaccine.2014.02.052 doi


Adolescent
Adult
Antibodies, Bacterial--blood
Bacterial Proteins--immunology
Double-Blind Method
Drug-Related Side Effects and Adverse Reactions--epidemiology
Female
Healthy Volunteers
Humans
Hydrolases--immunology
Male
Placebos--administration & dosage
Pneumococcal Vaccines--administration & dosage
Streptococcus pneumoniae--immunology
Streptolysins--immunology
Vaccination--adverse effects
Young Adult